Alan Burghauser
Pulmonary Disease · Union, NJNPI 1992806608
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations.
Across 445 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Actelion Pharmaceuticals US, Inc.$907
- AstraZeneca$865
- Sunovion Pharmaceuticals Inc.$615
- Philips North America LLC$484
- Boehringer Ingelheim$330
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,41599%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 105 | $1,257 |
| Actelion Pharmaceuticals US, Inc. | 60 | $907 |
| AstraZeneca | 29 | $865 |
| Sunovion Pharmaceuticals Inc. | 54 | $615 |
| Philips North America LLC | 26 | $484 |
| Boehringer Ingelheim | 26 | $330 |
| Bayer | 16 | $252 |
| Regeneron Healthcare Solutions, Inc. | 15 | $194 |
| Sanofi | 13 | $176 |
| United Therapeutics Corporation | 11 | $142 |
| Mallinckrodt Hospital Products Inc. | 10 | $138 |
| Mylan Specialty L.p. | 10 | $137 |
| Covis Pharma GmbH | 9 | $130 |
| Advanced Respiratory, Inc | 7 | $130 |
| Insmed, Inc. | 9 | $122 |
| Jazz Pharmaceuticals Inc. | 8 | $109 |
| Pfizer | 6 | $87 |
| ANI Pharmaceuticals, Inc. | 5 | $67 |
| Mallinckrodt Enterprises LLC | 4 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Gilead | 2 | $33 |
| Electromed, Inc. | 2 | $32 |
| Optinose US, Inc. | 2 | $27 |
| Resmed Corp | 1 | $26 |
| Grifols USA, LLC | 2 | $26 |
| Harmony Biosciences LLC | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Circassia Inc. | 1 | $13 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| Boston Scientific | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,502 in reported general payments places this provider in the 75th percentile of 472 pulmonary disease providers in New Jersey.
Other pulmonary disease in Union
- Ilia SegalUnion$14K
- Joseph HoffmanPark Ridge$1.1M
- Reynold PanettieriNew Brunswick$1M
- Robert SussmanSummit$551K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
- Richard MillerNewark$328K
- Jason ShatkinParamus$282K
- Anthony RickettiTrenton$225K
- Jeffrey MiskoffManasquan$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.